3/5
08:00 am
coll
Collegium to Present New Real-World Data at PainConnect 2026
Medium
Report
Collegium to Present New Real-World Data at PainConnect 2026
3/3
08:47 am
coll
Paris Hilton Shares Her Experience with JORNAY PM and Launches New 'Embrace Your Sparkle' Campaign with Collegium to Empower the ADHD Community [Yahoo! Finance]
Medium
Report
Paris Hilton Shares Her Experience with JORNAY PM and Launches New 'Embrace Your Sparkle' Campaign with Collegium to Empower the ADHD Community [Yahoo! Finance]
3/3
08:00 am
coll
Paris Hilton Shares Her Experience with JORNAY PM and Launches New 'Embrace Your Sparkle' Campaign with Collegium to Empower the ADHD Community
Medium
Report
Paris Hilton Shares Her Experience with JORNAY PM and Launches New 'Embrace Your Sparkle' Campaign with Collegium to Empower the ADHD Community
3/2
08:00 am
coll
Collegium to Participate in Upcoming Investor Conferences
Low
Report
Collegium to Participate in Upcoming Investor Conferences
2/28
12:43 am
coll
Why Collegium Pharmaceutical (COLL) Is Down 7.4% After Reaffirming 2026 Revenue Guidance Despite Earnings Miss [Yahoo! Finance]
Low
Report
Why Collegium Pharmaceutical (COLL) Is Down 7.4% After Reaffirming 2026 Revenue Guidance Despite Earnings Miss [Yahoo! Finance]
2/27
05:32 pm
coll
Why Collegium Pharmaceutical (COLL) Stock Is Trading Lower Today [Yahoo! Finance]
Low
Report
Why Collegium Pharmaceutical (COLL) Stock Is Trading Lower Today [Yahoo! Finance]
2/26
04:50 pm
coll
Collegium Pharmaceutical, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
Medium
Report
Collegium Pharmaceutical, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
2/26
03:26 pm
coll
Collegium (COLL) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Collegium (COLL) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
2/26
02:28 pm
coll
Collegium Pharmaceutical (COLL) had its price target lowered by Needham & Company LLC from $56.00 to $54.00. They now have a "buy" rating on the stock.
Low
Report
Collegium Pharmaceutical (COLL) had its price target lowered by Needham & Company LLC from $56.00 to $54.00. They now have a "buy" rating on the stock.
2/26
02:24 pm
coll
Collegium Pharmaceutical (COLL) Reports Q4 Earnings: What Key Metrics Have to Say [Yahoo! Finance]
Low
Report
Collegium Pharmaceutical (COLL) Reports Q4 Earnings: What Key Metrics Have to Say [Yahoo! Finance]
2/26
09:43 am
coll
Collegium Pharmaceutical Q4 Earnings Call Highlights [Yahoo! Finance]
Low
Report
Collegium Pharmaceutical Q4 Earnings Call Highlights [Yahoo! Finance]
2/26
08:53 am
coll
Collegium Pharmaceutical's (NASDAQ:COLL) Q4 CY2025 Earnings Results: Revenue In Line With Expectations [Yahoo! Finance]
Low
Report
Collegium Pharmaceutical's (NASDAQ:COLL) Q4 CY2025 Earnings Results: Revenue In Line With Expectations [Yahoo! Finance]
2/26
08:13 am
coll
Collegium Reports Fourth Quarter and Full-Year 2025 Financial Results [Yahoo! Finance]
Low
Report
Collegium Reports Fourth Quarter and Full-Year 2025 Financial Results [Yahoo! Finance]
2/26
07:59 am
coll
Collegium Pharmaceutical: Q4 Earnings Snapshot [Yahoo! Finance]
Low
Report
Collegium Pharmaceutical: Q4 Earnings Snapshot [Yahoo! Finance]
2/26
07:30 am
coll
Collegium Reports Fourth Quarter and Full-Year 2025 Financial Results
Low
Report
Collegium Reports Fourth Quarter and Full-Year 2025 Financial Results
2/24
11:16 pm
coll
Collegium Pharmaceutical (COLL) Q4 Earnings: What To Expect [Yahoo! Finance]
Low
Report
Collegium Pharmaceutical (COLL) Q4 Earnings: What To Expect [Yahoo! Finance]
2/23
08:13 am
coll
Boston Legacy FC Announces Sensory Room Sponsorship with Collegium Pharmaceutical [Yahoo! Finance]
Low
Report
Boston Legacy FC Announces Sensory Room Sponsorship with Collegium Pharmaceutical [Yahoo! Finance]
2/23
08:00 am
coll
Boston Legacy FC Announces Sensory Room Sponsorship with Collegium Pharmaceutical
Low
Report
Boston Legacy FC Announces Sensory Room Sponsorship with Collegium Pharmaceutical
2/18
04:32 am
coll
Collegium Pharmaceutical, Inc. (COLL) Gains Momentum on Jornay PM, Truist Highlights Robust Pain Portfolio [Yahoo! Finance]
Low
Report
Collegium Pharmaceutical, Inc. (COLL) Gains Momentum on Jornay PM, Truist Highlights Robust Pain Portfolio [Yahoo! Finance]
2/12
08:00 am
coll
Collegium to Report Fourth Quarter and Full-Year 2025 Financial Results on February 26, 2026
Low
Report
Collegium to Report Fourth Quarter and Full-Year 2025 Financial Results on February 26, 2026
2/10
11:08 am
coll
Collegium Pharmaceutical (NASDAQ:COLL) was given a new $58.00 price target on by analysts at Truist Financial Corporation.
Low
Report
Collegium Pharmaceutical (NASDAQ:COLL) was given a new $58.00 price target on by analysts at Truist Financial Corporation.
1/21
10:46 pm
coll
Collegium Pharmaceutical: Buying The Projected Growth For 2026 [Seeking Alpha]
Low
Report
Collegium Pharmaceutical: Buying The Projected Growth For 2026 [Seeking Alpha]
1/19
01:53 am
coll
A Look At Collegium Pharmaceutical (COLL) Valuation After Recent Share Price Swings [Yahoo! Finance]
Medium
Report
A Look At Collegium Pharmaceutical (COLL) Valuation After Recent Share Price Swings [Yahoo! Finance]
1/15
08:00 am
coll
Collegium to Present Four Real-World Data Posters at APSARD 2026 Annual Conference
Low
Report
Collegium to Present Four Real-World Data Posters at APSARD 2026 Annual Conference
1/14
05:36 am
coll
Collegium Pharmaceutical EVP Sells COLL 17,600 Shares Amid Strong Close of 2025 [Yahoo! Finance]
Low
Report
Collegium Pharmaceutical EVP Sells COLL 17,600 Shares Amid Strong Close of 2025 [Yahoo! Finance]